N/A
N=47
Chronic-disease Self-management Program in Patients Living With Long-COVID in Puerto Rico
Long Covid19
Bottom Line
View on ClinicalTrials.gov: NCT06208696 ↗Enrolled (actual)
47
Serious AEs
0.0%
Results posted
May 2026
Primary outcome: Primary: Assessment of the Impact of Health-related Quality of Life — 4; 3; 4; 6 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- "Tomando control de su salud" (Spanish Chronic Disease Self-Management) (Other)
- Age
- Adult, Older Adult · 21+ yrs
- Sex
- All
- Sponsor
- University of Puerto Rico
- Primary completion
- Feb 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Assessment of the Impact of Health-related Quality of Life |
4; 3; 4; 6; 2; 3 | — |
| PRIMARY Assessment of the Fatigue in the Impact of the Health-related Quality of Life |
9; 19; 9; 20 | — |
| PRIMARY Assessment of the Anxiety in the Impact of Health-related Quality of Life |
2; 6; 1; 11 | — |
| SECONDARY Chronic Diseases Self-management |
1; 4; 3; 6 | — |
| SECONDARY Auto-efficacy for Disease Management |
11; 27; 11; 31; 12; 32 | — |
Summary
This is a pilot non-randomized-controlled trial to evaluate the impact of "Tomando control de su salud", an evidenced-based intervention for chronic disease self-management in the quality of life of patients living with Long-COVID in Puerto Rico.
Eligibility Criteria
Inclusion Criteria
- Adult patients 21 years or older;
- Participant of PR COAS-cohort that completed the last interview (12-month-follow-up) and authorized to be contacted for further studies;
- Having at least one chronic condition (excluding cancer) diagnosed by a physician or healthcare provider, and
- Ability to attend weekly sessions.
Exclusion Criteria
- Any clinical or cognitive impairment that limits the participant's ability to decide to participate in the study or complete the interviews;
- presence of a life threatening or extreme medical condition, and
- planning to move out of the municipality within the next year.
Data sourced from ClinicalTrials.gov (NCT06208696). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.